The clinical spectrum of acute renal infarction

Acute renal infarction is an oft-missed diagnosis. As a result, its true incidence, although presumed to be low, is actually unknown. Surprisingly, the medical literature on the subject, other than anecdotal case reports, is scarce. To increase physician awareness of the diagnosis and to identify pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Israel Medical Association journal 2002-10, Vol.4 (10), p.781-784
Hauptverfasser: Korzets, Ze'ev, Plotkin, Eleanora, Bernheim, Jacques, Zissin, Rivka
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 784
container_issue 10
container_start_page 781
container_title The Israel Medical Association journal
container_volume 4
creator Korzets, Ze'ev
Plotkin, Eleanora
Bernheim, Jacques
Zissin, Rivka
description Acute renal infarction is an oft-missed diagnosis. As a result, its true incidence, although presumed to be low, is actually unknown. Surprisingly, the medical literature on the subject, other than anecdotal case reports, is scarce. To increase physician awareness of the diagnosis and to identify predictive clinical and laboratory features of the entity. Between 1 November 1997 and 31 October 2000, 11 cases of acute renal infarction in 10 patients were diagnosed in our center by contrast-enhanced computerized tomography. The medical charts of these patients were reviewed regarding risk factors, clinical presentation, possible predictive laboratory examinations, and outcome. During the 36 month observation period, the incidence of acute renal infarction was 0.007%. The mean age of the patients (5 men and 5 women) was 67.4 +/- 21.1 (range 30-87 years). In four cases the right and in five the left kidney was involved; in the other two cases bilateral involvement was seen. In 7/10 patients, an increased risk for thromboembolic events was found. Six had chronic atrial fibrillation and one had a combined activated protein C resistance and protein S deficiency. Three patients had suffered a previous thromboembolic event. Two cases were receiving anticoagulant therapy with an INR of 1.6 and 1.8, respectively. On admission, flank pain was recorded in 10/11, fever in 5 and nausea/vomiting in 4 cases. Hematuria was detected in urine reagent strips in all cases. Serum lactate dehydrogenase and white blood cell count were elevated in all cases (1,570 +/- 703 IU/L and 12,988 +/- 3,841/microliter, respectively). In no case was the diagnosis of acute renal infarction initially entertained. The working diagnoses were renal colic in 2, pyelonephritis in 3, renal carcinoma, digitalis intoxication, and suspected endocarditis in one patient each, and an acute abdomen in 3. Time from admission to definitive CT diagnosis ranged from 24 hours to 6 days. Three patients were treated with intravenous heparin and another with a combination of i.v. heparin and renal intra-arterial urokinase infusion with, in the latter case, no recovery of function of the affected kidney. With the exception of this one patient (with a contralateral contracted kidney) who required maintenance dialysis, in all other cases serum creatinine levels remained unchanged or reverted to the baseline mean of 1.1 mg/dl (0.9-1.2). Acute renal infarction is not as rare as previously assumed. The entity is often mis
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72192902</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72192902</sourcerecordid><originalsourceid>FETCH-LOGICAL-p207t-9d41c1e5c3711ea3b46c7039bb35e0865743bc3104b4586996bdeab364fa10a33</originalsourceid><addsrcrecordid>eNo1jztLBDEURlMo7rr6FySV3eBNbpKZlLL4ggWbtR6SzB2MzMskU_jvXXCtDnwcPjgXbCu00ZWAptmw65y_AKTWYK_YRkhsLCrYsofjJ_EwxCkGN_C8UChpHfnccxfWQjzRdNrj1LsUSpynG3bZuyHT7Zk79vH8dNy_Vof3l7f946FaJNSlsp0SQZAOWAtBDr0yoQa03qMmaIyuFfqAApRXujHWGt-R82hU7wQ4xB27__td0vy9Ui7tGHOgYXATzWtuaymstCBP4t1ZXP1IXbukOLr00_4n4i8Pj0qo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72192902</pqid></control><display><type>article</type><title>The clinical spectrum of acute renal infarction</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Korzets, Ze'ev ; Plotkin, Eleanora ; Bernheim, Jacques ; Zissin, Rivka</creator><creatorcontrib>Korzets, Ze'ev ; Plotkin, Eleanora ; Bernheim, Jacques ; Zissin, Rivka</creatorcontrib><description>Acute renal infarction is an oft-missed diagnosis. As a result, its true incidence, although presumed to be low, is actually unknown. Surprisingly, the medical literature on the subject, other than anecdotal case reports, is scarce. To increase physician awareness of the diagnosis and to identify predictive clinical and laboratory features of the entity. Between 1 November 1997 and 31 October 2000, 11 cases of acute renal infarction in 10 patients were diagnosed in our center by contrast-enhanced computerized tomography. The medical charts of these patients were reviewed regarding risk factors, clinical presentation, possible predictive laboratory examinations, and outcome. During the 36 month observation period, the incidence of acute renal infarction was 0.007%. The mean age of the patients (5 men and 5 women) was 67.4 +/- 21.1 (range 30-87 years). In four cases the right and in five the left kidney was involved; in the other two cases bilateral involvement was seen. In 7/10 patients, an increased risk for thromboembolic events was found. Six had chronic atrial fibrillation and one had a combined activated protein C resistance and protein S deficiency. Three patients had suffered a previous thromboembolic event. Two cases were receiving anticoagulant therapy with an INR of 1.6 and 1.8, respectively. On admission, flank pain was recorded in 10/11, fever in 5 and nausea/vomiting in 4 cases. Hematuria was detected in urine reagent strips in all cases. Serum lactate dehydrogenase and white blood cell count were elevated in all cases (1,570 +/- 703 IU/L and 12,988 +/- 3,841/microliter, respectively). In no case was the diagnosis of acute renal infarction initially entertained. The working diagnoses were renal colic in 2, pyelonephritis in 3, renal carcinoma, digitalis intoxication, and suspected endocarditis in one patient each, and an acute abdomen in 3. Time from admission to definitive CT diagnosis ranged from 24 hours to 6 days. Three patients were treated with intravenous heparin and another with a combination of i.v. heparin and renal intra-arterial urokinase infusion with, in the latter case, no recovery of function of the affected kidney. With the exception of this one patient (with a contralateral contracted kidney) who required maintenance dialysis, in all other cases serum creatinine levels remained unchanged or reverted to the baseline mean of 1.1 mg/dl (0.9-1.2). Acute renal infarction is not as rare as previously assumed. The entity is often misdiagnosed. Unilateral flank pain in a patient with an increased risk for thromboembolism should raise the suspicion of renal infarction. In such a setting, hematuria, leucocytosis and an elevated LDH level are strongly supportive of the diagnosis.</description><identifier>ISSN: 1565-1088</identifier><identifier>PMID: 12389340</identifier><language>eng</language><publisher>Israel</publisher><subject>Acute Disease ; Adult ; Aged ; Aged, 80 and over ; Anticoagulants - administration &amp; dosage ; Anticoagulants - therapeutic use ; Clinical Enzyme Tests ; Creatinine - blood ; Diagnosis, Differential ; Female ; Fibrinolytic Agents - administration &amp; dosage ; Fibrinolytic Agents - therapeutic use ; Follow-Up Studies ; Hematuria - etiology ; Heparin - administration &amp; dosage ; Heparin - therapeutic use ; Humans ; Infarction - diagnosis ; Infarction - diagnostic imaging ; Infarction - drug therapy ; Infusions, Intra-Arterial ; Injections, Intravenous ; Kidney - blood supply ; Kidney - diagnostic imaging ; L-Lactate Dehydrogenase - blood ; Leukocyte Count ; Male ; Middle Aged ; Plasminogen Activators - administration &amp; dosage ; Plasminogen Activators - therapeutic use ; Risk Factors ; Time Factors ; Tomography, X-Ray Computed ; Treatment Outcome ; Urokinase-Type Plasminogen Activator - administration &amp; dosage ; Urokinase-Type Plasminogen Activator - therapeutic use</subject><ispartof>The Israel Medical Association journal, 2002-10, Vol.4 (10), p.781-784</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12389340$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Korzets, Ze'ev</creatorcontrib><creatorcontrib>Plotkin, Eleanora</creatorcontrib><creatorcontrib>Bernheim, Jacques</creatorcontrib><creatorcontrib>Zissin, Rivka</creatorcontrib><title>The clinical spectrum of acute renal infarction</title><title>The Israel Medical Association journal</title><addtitle>Isr Med Assoc J</addtitle><description>Acute renal infarction is an oft-missed diagnosis. As a result, its true incidence, although presumed to be low, is actually unknown. Surprisingly, the medical literature on the subject, other than anecdotal case reports, is scarce. To increase physician awareness of the diagnosis and to identify predictive clinical and laboratory features of the entity. Between 1 November 1997 and 31 October 2000, 11 cases of acute renal infarction in 10 patients were diagnosed in our center by contrast-enhanced computerized tomography. The medical charts of these patients were reviewed regarding risk factors, clinical presentation, possible predictive laboratory examinations, and outcome. During the 36 month observation period, the incidence of acute renal infarction was 0.007%. The mean age of the patients (5 men and 5 women) was 67.4 +/- 21.1 (range 30-87 years). In four cases the right and in five the left kidney was involved; in the other two cases bilateral involvement was seen. In 7/10 patients, an increased risk for thromboembolic events was found. Six had chronic atrial fibrillation and one had a combined activated protein C resistance and protein S deficiency. Three patients had suffered a previous thromboembolic event. Two cases were receiving anticoagulant therapy with an INR of 1.6 and 1.8, respectively. On admission, flank pain was recorded in 10/11, fever in 5 and nausea/vomiting in 4 cases. Hematuria was detected in urine reagent strips in all cases. Serum lactate dehydrogenase and white blood cell count were elevated in all cases (1,570 +/- 703 IU/L and 12,988 +/- 3,841/microliter, respectively). In no case was the diagnosis of acute renal infarction initially entertained. The working diagnoses were renal colic in 2, pyelonephritis in 3, renal carcinoma, digitalis intoxication, and suspected endocarditis in one patient each, and an acute abdomen in 3. Time from admission to definitive CT diagnosis ranged from 24 hours to 6 days. Three patients were treated with intravenous heparin and another with a combination of i.v. heparin and renal intra-arterial urokinase infusion with, in the latter case, no recovery of function of the affected kidney. With the exception of this one patient (with a contralateral contracted kidney) who required maintenance dialysis, in all other cases serum creatinine levels remained unchanged or reverted to the baseline mean of 1.1 mg/dl (0.9-1.2). Acute renal infarction is not as rare as previously assumed. The entity is often misdiagnosed. Unilateral flank pain in a patient with an increased risk for thromboembolism should raise the suspicion of renal infarction. In such a setting, hematuria, leucocytosis and an elevated LDH level are strongly supportive of the diagnosis.</description><subject>Acute Disease</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anticoagulants - administration &amp; dosage</subject><subject>Anticoagulants - therapeutic use</subject><subject>Clinical Enzyme Tests</subject><subject>Creatinine - blood</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>Fibrinolytic Agents - administration &amp; dosage</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Follow-Up Studies</subject><subject>Hematuria - etiology</subject><subject>Heparin - administration &amp; dosage</subject><subject>Heparin - therapeutic use</subject><subject>Humans</subject><subject>Infarction - diagnosis</subject><subject>Infarction - diagnostic imaging</subject><subject>Infarction - drug therapy</subject><subject>Infusions, Intra-Arterial</subject><subject>Injections, Intravenous</subject><subject>Kidney - blood supply</subject><subject>Kidney - diagnostic imaging</subject><subject>L-Lactate Dehydrogenase - blood</subject><subject>Leukocyte Count</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Plasminogen Activators - administration &amp; dosage</subject><subject>Plasminogen Activators - therapeutic use</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><subject>Urokinase-Type Plasminogen Activator - administration &amp; dosage</subject><subject>Urokinase-Type Plasminogen Activator - therapeutic use</subject><issn>1565-1088</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1jztLBDEURlMo7rr6FySV3eBNbpKZlLL4ggWbtR6SzB2MzMskU_jvXXCtDnwcPjgXbCu00ZWAptmw65y_AKTWYK_YRkhsLCrYsofjJ_EwxCkGN_C8UChpHfnccxfWQjzRdNrj1LsUSpynG3bZuyHT7Zk79vH8dNy_Vof3l7f946FaJNSlsp0SQZAOWAtBDr0yoQa03qMmaIyuFfqAApRXujHWGt-R82hU7wQ4xB27__td0vy9Ui7tGHOgYXATzWtuaymstCBP4t1ZXP1IXbukOLr00_4n4i8Pj0qo</recordid><startdate>200210</startdate><enddate>200210</enddate><creator>Korzets, Ze'ev</creator><creator>Plotkin, Eleanora</creator><creator>Bernheim, Jacques</creator><creator>Zissin, Rivka</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200210</creationdate><title>The clinical spectrum of acute renal infarction</title><author>Korzets, Ze'ev ; Plotkin, Eleanora ; Bernheim, Jacques ; Zissin, Rivka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p207t-9d41c1e5c3711ea3b46c7039bb35e0865743bc3104b4586996bdeab364fa10a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Acute Disease</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anticoagulants - administration &amp; dosage</topic><topic>Anticoagulants - therapeutic use</topic><topic>Clinical Enzyme Tests</topic><topic>Creatinine - blood</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>Fibrinolytic Agents - administration &amp; dosage</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Follow-Up Studies</topic><topic>Hematuria - etiology</topic><topic>Heparin - administration &amp; dosage</topic><topic>Heparin - therapeutic use</topic><topic>Humans</topic><topic>Infarction - diagnosis</topic><topic>Infarction - diagnostic imaging</topic><topic>Infarction - drug therapy</topic><topic>Infusions, Intra-Arterial</topic><topic>Injections, Intravenous</topic><topic>Kidney - blood supply</topic><topic>Kidney - diagnostic imaging</topic><topic>L-Lactate Dehydrogenase - blood</topic><topic>Leukocyte Count</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Plasminogen Activators - administration &amp; dosage</topic><topic>Plasminogen Activators - therapeutic use</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><topic>Urokinase-Type Plasminogen Activator - administration &amp; dosage</topic><topic>Urokinase-Type Plasminogen Activator - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Korzets, Ze'ev</creatorcontrib><creatorcontrib>Plotkin, Eleanora</creatorcontrib><creatorcontrib>Bernheim, Jacques</creatorcontrib><creatorcontrib>Zissin, Rivka</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The Israel Medical Association journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Korzets, Ze'ev</au><au>Plotkin, Eleanora</au><au>Bernheim, Jacques</au><au>Zissin, Rivka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The clinical spectrum of acute renal infarction</atitle><jtitle>The Israel Medical Association journal</jtitle><addtitle>Isr Med Assoc J</addtitle><date>2002-10</date><risdate>2002</risdate><volume>4</volume><issue>10</issue><spage>781</spage><epage>784</epage><pages>781-784</pages><issn>1565-1088</issn><abstract>Acute renal infarction is an oft-missed diagnosis. As a result, its true incidence, although presumed to be low, is actually unknown. Surprisingly, the medical literature on the subject, other than anecdotal case reports, is scarce. To increase physician awareness of the diagnosis and to identify predictive clinical and laboratory features of the entity. Between 1 November 1997 and 31 October 2000, 11 cases of acute renal infarction in 10 patients were diagnosed in our center by contrast-enhanced computerized tomography. The medical charts of these patients were reviewed regarding risk factors, clinical presentation, possible predictive laboratory examinations, and outcome. During the 36 month observation period, the incidence of acute renal infarction was 0.007%. The mean age of the patients (5 men and 5 women) was 67.4 +/- 21.1 (range 30-87 years). In four cases the right and in five the left kidney was involved; in the other two cases bilateral involvement was seen. In 7/10 patients, an increased risk for thromboembolic events was found. Six had chronic atrial fibrillation and one had a combined activated protein C resistance and protein S deficiency. Three patients had suffered a previous thromboembolic event. Two cases were receiving anticoagulant therapy with an INR of 1.6 and 1.8, respectively. On admission, flank pain was recorded in 10/11, fever in 5 and nausea/vomiting in 4 cases. Hematuria was detected in urine reagent strips in all cases. Serum lactate dehydrogenase and white blood cell count were elevated in all cases (1,570 +/- 703 IU/L and 12,988 +/- 3,841/microliter, respectively). In no case was the diagnosis of acute renal infarction initially entertained. The working diagnoses were renal colic in 2, pyelonephritis in 3, renal carcinoma, digitalis intoxication, and suspected endocarditis in one patient each, and an acute abdomen in 3. Time from admission to definitive CT diagnosis ranged from 24 hours to 6 days. Three patients were treated with intravenous heparin and another with a combination of i.v. heparin and renal intra-arterial urokinase infusion with, in the latter case, no recovery of function of the affected kidney. With the exception of this one patient (with a contralateral contracted kidney) who required maintenance dialysis, in all other cases serum creatinine levels remained unchanged or reverted to the baseline mean of 1.1 mg/dl (0.9-1.2). Acute renal infarction is not as rare as previously assumed. The entity is often misdiagnosed. Unilateral flank pain in a patient with an increased risk for thromboembolism should raise the suspicion of renal infarction. In such a setting, hematuria, leucocytosis and an elevated LDH level are strongly supportive of the diagnosis.</abstract><cop>Israel</cop><pmid>12389340</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1565-1088
ispartof The Israel Medical Association journal, 2002-10, Vol.4 (10), p.781-784
issn 1565-1088
language eng
recordid cdi_proquest_miscellaneous_72192902
source MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Acute Disease
Adult
Aged
Aged, 80 and over
Anticoagulants - administration & dosage
Anticoagulants - therapeutic use
Clinical Enzyme Tests
Creatinine - blood
Diagnosis, Differential
Female
Fibrinolytic Agents - administration & dosage
Fibrinolytic Agents - therapeutic use
Follow-Up Studies
Hematuria - etiology
Heparin - administration & dosage
Heparin - therapeutic use
Humans
Infarction - diagnosis
Infarction - diagnostic imaging
Infarction - drug therapy
Infusions, Intra-Arterial
Injections, Intravenous
Kidney - blood supply
Kidney - diagnostic imaging
L-Lactate Dehydrogenase - blood
Leukocyte Count
Male
Middle Aged
Plasminogen Activators - administration & dosage
Plasminogen Activators - therapeutic use
Risk Factors
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
Urokinase-Type Plasminogen Activator - administration & dosage
Urokinase-Type Plasminogen Activator - therapeutic use
title The clinical spectrum of acute renal infarction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T14%3A04%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20clinical%20spectrum%20of%20acute%20renal%20infarction&rft.jtitle=The%20Israel%20Medical%20Association%20journal&rft.au=Korzets,%20Ze'ev&rft.date=2002-10&rft.volume=4&rft.issue=10&rft.spage=781&rft.epage=784&rft.pages=781-784&rft.issn=1565-1088&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72192902%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72192902&rft_id=info:pmid/12389340&rfr_iscdi=true